iShares Core High Dividend ETF (HDV)
| Assets | $15.02B |
| Expense Ratio | 0.08% |
| PE Ratio | 20.00 |
| Shares Out | 511.85M |
| Dividend (ttm) | $0.88 |
| Dividend Yield | 3.01% |
| Ex-Dividend Date | Jul 15, 2026 |
| Payout Frequency | Monthly |
| Payout Ratio | 60.09% |
| Volume | 2,230,011 |
| Open | 29.24 |
| Previous Close | 29.26 |
| Day's Range | 29.22 - 29.40 |
| 52-Week Low | 23.52 |
| 52-Week High | 29.61 |
| Beta | 0.55 |
| Holdings | 82 |
| Inception Date | Mar 29, 2011 |
About HDV
Fund Home PageThe iShares Core High Dividend ETF (HDV) is an exchange-traded fund that is based on the Morningstar Dividend Yield Focus index. The fund tracks a dividend-weighted index of 75 high-yielding US equities, screened for high earnings potential and dividend sustainability. HDV was launched on Mar 29, 2011 and is issued by BlackRock.
Top 10 Holdings
51.36% of assets| Name | Symbol | Weight |
|---|---|---|
| ExxonMobil Holdings Corporation | XOM | 7.89% |
| AbbVie Inc. | ABBV | 6.04% |
| Chevron Corporation | CVX | 6.04% |
| Verizon Communications Inc. | VZ | 5.57% |
| The Home Depot, Inc. | HD | 4.50% |
| Pfizer Inc. | PFE | 4.49% |
| The Procter & Gamble Company | PG | 4.43% |
| Philip Morris International Inc. | PM | 4.32% |
| Merck & Co., Inc. | MRK | 4.07% |
| The Coca-Cola Company | KO | 4.01% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jul 15, 2026 | $0.08739 | Jul 20, 2026 |
| Jun 15, 2026 | $0.18505 | Jun 18, 2026 |
| Mar 17, 2026 | $0.16859 | Mar 20, 2026 |
| Dec 16, 2025 | $0.25058 | Dec 19, 2025 |
| Sep 16, 2025 | $0.18992 | Sep 19, 2025 |
| Jun 16, 2025 | $0.18262 | Jun 20, 2025 |
Performance
HDV had a total return of 24.80% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.95%.
News
Supermajor Earnings: Exxon & Chevron's Impact on ETF Market
The two largest U.S. integrated supermajors, Exxon Mobil (XOM) and Chevron (CVX), reported second-quarter profits that surged on rising oil prices due to renewed geopolitical tensions in the Middle Ea...
FDA Grants Accelerated Approval to Gilead's Hepcludex® (bulevirtide-gmod), the First and Only Approved Treatment for Chronic Hepatitis Delta Virus (HDV)
FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Hepcludex® (bulevirtide...
DGRO vs. HDV: Which BlackRock iShares Dividend ETF Pays More Income?
Investors looking for dividend income often compare BlackRock’s ($BLK) iShares Core Dividend Growth ETF ($DGRO) and iShares Core High Dividend ETF ($HDV). Using TipRanks’ Best BlackRock ETFs tool, we ...
The 3 best ETFs for dividends
The market's recent shellacking hasn't exactly been uniform; growth stocks have really taken it on the chin. And their sell-off may not be over yet.
Here's how dividend-based ETFs are managing shareholder payout cuts: Issuer
Simeon Hyman of ProShares, Dave Nadig of ETF Trends and Chris Hempstead of IndexIQ talk what could lie ahead for dividend-based ETFs as corporations cut their shareholder payouts. With CNBC's Bob Pisa...
Shareholder payouts are under siege. What that could mean for dividend-based ETFs
Dividend-paying ETFs could take a back seat to other factor-focused funds, two ETF analysts say.
As companies cut their dividends, here's what could lie ahead for dividend-paying ETFs
Mike Akins, founding partner of ETF Action, and Bryon Lake, head of Americas ETF distribution at J.P. Morgan Asset Management, discuss the fate of dividend ETFs with CNBC's Bob Pisani as companies sla...